Stage
No active trials
Next date
None yet
Trials
0 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Administered as inhalation using a Philips Micro device inhaler.”In the company’s words, NCT06193031 on ClinicalTrials.gov
- Main trialPhase 1
- “The primary purpose of this study is to determine the safety and tolerability of escalating doses of C16TR for inhalation in healthy participants.”In the company’s words, NCT06193031 on ClinicalTrials.gov
- Other names
- Hexadecyl-treprostinil
- Copy of
- Tyvaso (United Therap)Tested side by side with the original in NCT06193031
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Completed | 18 Dec 2015 | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026